55 % of patients who received anistreplase and 53 % of patients who received streptokinase had patent infarct-related arteries ( timi grade 2-3 ) at 90 min ( 95 % ci 42-68 % and 40-66 % , respectively ) .
C0078956
anistreplase
C0038418
streptokinase